Publications
5803 Results
- Journal / Conference
- Journal for ImmunoTherapy of Cancer Nov, 8 (Suppl 3) A288; Society for Immunotherapy of Cancer (SITC) Annual Meeting (November 10-15, 2020, virtual), poster
- Year
- 2020
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Thyroid Tumor Cohort
- Journal / Conference
- Lancet Oncology Dec;21(12):1589-1601; Oct 27;. doi: 10.1016/S1470-2045(20)30475-7. [Epub ahead of print]
- Year
- 2020
- Research Committee(s)
- Lung
- PMID
- PMID33125909
- PMC
- PMC8109255
- Study Number(s)
- S1400
Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
- Journal / Conference
- Value in Health Dec;23(12):1653-1661. doi: 10.1016/j.jval.2020.08.2095. Epub 2020 Oct 9
- Year
- 2020
- Research Committee(s)
- Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, and Lymphoma
- PMID
- PMID33248521
- PMC
- PMC8262264
- Study Number(s)
- CTSU/E2100, E4494, JMA17, N9741, N9831, SWOG-8494 (INT-0036), SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8794, SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-9031, SWOG-9412, SWOG-9509
Economic evaluations in NCI-sponsored network cancer clinical trials
- Journal / Conference
- American Association for Cancer Research Annual Meeting 2020, #1200, poster
- Year
- 2020
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk
- Journal / Conference
- JCO Precision Oncology May 15;4:PO.18.00391
- Year
- 2020
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID33215052
- PMC
- PMC7670562
- Study Number(s)
- S1609
Dual Checkpoint Blockade in a Neuroendocrine Carcinoma with Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden [case report]
- Journal / Conference
- JAMA Network Open Oct 1;3(10):e2023500
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID33125497
- PMC
- PMC7599454
- Study Number(s)
- CTSU/C80405
Association of diet quality with survival among people with metastatic colorectal cancer: data from CALGB/SWOG 80405 (Alliance)
- Journal / Conference
- American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #1324, poster
- Year
- 2020
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
Multiethnic Genomic and Transcriptomic Association Studies Identifies New Susceptibility Loci for Prostate Cancer
- Journal / Conference
- American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #2410, poster
- Year
- 2020
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000, SWOG-9217
Rare germline variants in ATM predispose to prostate cancer: A PRACTICAL Consortium study
- Journal / Conference
- J Clin Oncol 38, 2020 (suppl 6; abstr 106); ASCO GU Cancers Symposium 2020, poster
- Year
- 2020
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0925
Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of androgen deprivation (AD) +/- cixutumumab in new metastatic hormone-sensitive prostate cancer (mHSPC)
- Journal / Conference
- Cancer Discovery Oct;10(10):1514-1527
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID32699031
- PMC
- PMC7541683